Industry: Chemical & Material
Published Date: 2025-02-24
Pages: 100 Pages
Report ld: 4214837
Request Sample
Customized Report
The global Febantel market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
The North America Febantel market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Febantel include Pure Chemistry Scientific, LGM Pharma, BOC Sciences, TCI, HBCChem, Toronto Research Chemicals, Texas Biochemicals, Waterstone Technology, 2A PharmaChem, 3B Scientific, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Febantel market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Febantel market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales and revenue of Febantel in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.
Chapter 3: Detailed analysis of Febantel manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Febantel revenue, gross margin, and recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Sales channels analysis
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Febantel Product Scope
1.2 Febantel by Type
1.2.1 Global Febantel Sales by Type (2020 & 2024 & 2031)
1.2.2 Purity 98%
1.2.3 Purity 99%
1.2.4 Others
1.3 Febantel by Application
1.3.1 Global Febantel Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Chemical Reagents
1.3.3 Pharmaceutical Intermediates
1.3.4 Others
1.4 Global Febantel Market Estimates and Forecasts (2020-2031)
1.4.1 Global Febantel Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Febantel Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Febantel Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Febantel Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Febantel Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Febantel Sales Market Share by Region (2020-2025)
2.2.2 Global Febantel Revenue Market Share by Region (2020-2025)
2.3 Global Febantel Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Febantel Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Febantel Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Febantel Market Size and Prospective (2020-2031)
2.4.2 Europe Febantel Market Size and Prospective (2020-2031)
2.4.3 China Febantel Market Size and Prospective (2020-2031)
2.4.4 Japan Febantel Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Febantel Historic Market Review by Type (2020-2025)
3.1.1 Global Febantel Sales by Type (2020-2025)
3.1.2 Global Febantel Revenue by Type (2020-2025)
3.1.3 Global Febantel Price by Type (2020-2025)
3.2 Global Febantel Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Febantel Sales Forecast by Type (2026-2031)
3.2.2 Global Febantel Revenue Forecast by Type (2026-2031)
3.2.3 Global Febantel Price Forecast by Type (2026-2031)
3.3 Different Types Febantel Representative Players
4 Global Market Size by Application
4.1 Global Febantel Historic Market Review by Application (2020-2025)
4.1.1 Global Febantel Sales by Application (2020-2025)
4.1.2 Global Febantel Revenue by Application (2020-2025)
4.1.3 Global Febantel Price by Application (2020-2025)
4.2 Global Febantel Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Febantel Sales Forecast by Application (2026-2031)
4.2.2 Global Febantel Revenue Forecast by Application (2026-2031)
4.2.3 Global Febantel Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Febantel Application
5 Competition Landscape by Players
5.1 Global Febantel Sales by Players (2020-2025)
5.2 Global Top Febantel Players by Revenue (2020-2025)
5.3 Global Febantel Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Febantel as of 2024)
5.4 Global Febantel Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Febantel, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Febantel, Product Type & Application
5.7 Global Key Manufacturers of Febantel, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Febantel Sales by Company
6.1.1.1 North America Febantel Sales by Company (2020-2025)
6.1.1.2 North America Febantel Revenue by Company (2020-2025)
6.1.2 North America Febantel Sales Breakdown by Type (2020-2025)
6.1.3 North America Febantel Sales Breakdown by Application (2020-2025)
6.1.4 North America Febantel Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Febantel Sales by Company
6.2.1.1 Europe Febantel Sales by Company (2020-2025)
6.2.1.2 Europe Febantel Revenue by Company (2020-2025)
6.2.2 Europe Febantel Sales Breakdown by Type (2020-2025)
6.2.3 Europe Febantel Sales Breakdown by Application (2020-2025)
6.2.4 Europe Febantel Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Febantel Sales by Company
6.3.1.1 China Febantel Sales by Company (2020-2025)
6.3.1.2 China Febantel Revenue by Company (2020-2025)
6.3.2 China Febantel Sales Breakdown by Type (2020-2025)
6.3.3 China Febantel Sales Breakdown by Application (2020-2025)
6.3.4 China Febantel Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Febantel Sales by Company
6.4.1.1 Japan Febantel Sales by Company (2020-2025)
6.4.1.2 Japan Febantel Revenue by Company (2020-2025)
6.4.2 Japan Febantel Sales Breakdown by Type (2020-2025)
6.4.3 Japan Febantel Sales Breakdown by Application (2020-2025)
6.4.4 Japan Febantel Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Pure Chemistry Scientific
7.1.1 Pure Chemistry Scientific Company Information
7.1.2 Pure Chemistry Scientific Business Overview
7.1.3 Pure Chemistry Scientific Febantel Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Pure Chemistry Scientific Febantel Products Offered
7.1.5 Pure Chemistry Scientific Recent Development
7.2 LGM Pharma
7.2.1 LGM Pharma Company Information
7.2.2 LGM Pharma Business Overview
7.2.3 LGM Pharma Febantel Sales, Revenue and Gross Margin (2020-2025)
7.2.4 LGM Pharma Febantel Products Offered
7.2.5 LGM Pharma Recent Development
7.3 BOC Sciences
7.3.1 BOC Sciences Company Information
7.3.2 BOC Sciences Business Overview
7.3.3 BOC Sciences Febantel Sales, Revenue and Gross Margin (2020-2025)
7.3.4 BOC Sciences Febantel Products Offered
7.3.5 BOC Sciences Recent Development
7.4 TCI
7.4.1 TCI Company Information
7.4.2 TCI Business Overview
7.4.3 TCI Febantel Sales, Revenue and Gross Margin (2020-2025)
7.4.4 TCI Febantel Products Offered
7.4.5 TCI Recent Development
7.5 HBCChem
7.5.1 HBCChem Company Information
7.5.2 HBCChem Business Overview
7.5.3 HBCChem Febantel Sales, Revenue and Gross Margin (2020-2025)
7.5.4 HBCChem Febantel Products Offered
7.5.5 HBCChem Recent Development
7.6 Toronto Research Chemicals
7.6.1 Toronto Research Chemicals Company Information
7.6.2 Toronto Research Chemicals Business Overview
7.6.3 Toronto Research Chemicals Febantel Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Toronto Research Chemicals Febantel Products Offered
7.6.5 Toronto Research Chemicals Recent Development
7.7 Texas Biochemicals
7.7.1 Texas Biochemicals Company Information
7.7.2 Texas Biochemicals Business Overview
7.7.3 Texas Biochemicals Febantel Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Texas Biochemicals Febantel Products Offered
7.7.5 Texas Biochemicals Recent Development
7.8 Waterstone Technology
7.8.1 Waterstone Technology Company Information
7.8.2 Waterstone Technology Business Overview
7.8.3 Waterstone Technology Febantel Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Waterstone Technology Febantel Products Offered
7.8.5 Waterstone Technology Recent Development
7.9 2A PharmaChem
7.9.1 2A PharmaChem Company Information
7.9.2 2A PharmaChem Business Overview
7.9.3 2A PharmaChem Febantel Sales, Revenue and Gross Margin (2020-2025)
7.9.4 2A PharmaChem Febantel Products Offered
7.9.5 2A PharmaChem Recent Development
7.10 3B Scientific
7.10.1 3B Scientific Company Information
7.10.2 3B Scientific Business Overview
7.10.3 3B Scientific Febantel Sales, Revenue and Gross Margin (2020-2025)
7.10.4 3B Scientific Febantel Products Offered
7.10.5 3B Scientific Recent Development
7.11 J & K SCIENTIFIC
7.11.1 J & K SCIENTIFIC Company Information
7.11.2 J & K SCIENTIFIC Business Overview
7.11.3 J & K SCIENTIFIC Febantel Sales, Revenue and Gross Margin (2020-2025)
7.11.4 J & K SCIENTIFIC Febantel Products Offered
7.11.5 J & K SCIENTIFIC Recent Development
7.12 XiaoGan ShenYuan ChemPharm
7.12.1 XiaoGan ShenYuan ChemPharm Company Information
7.12.2 XiaoGan ShenYuan ChemPharm Business Overview
7.12.3 XiaoGan ShenYuan ChemPharm Febantel Sales, Revenue and Gross Margin (2020-2025)
7.12.4 XiaoGan ShenYuan ChemPharm Febantel Products Offered
7.12.5 XiaoGan ShenYuan ChemPharm Recent Development
7.13 Wuhan Fortuna Chemical
7.13.1 Wuhan Fortuna Chemical Company Information
7.13.2 Wuhan Fortuna Chemical Business Overview
7.13.3 Wuhan Fortuna Chemical Febantel Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Wuhan Fortuna Chemical Febantel Products Offered
7.13.5 Wuhan Fortuna Chemical Recent Development
7.14 Shanghai Haoyuan Chemexpress
7.14.1 Shanghai Haoyuan Chemexpress Company Information
7.14.2 Shanghai Haoyuan Chemexpress Business Overview
7.14.3 Shanghai Haoyuan Chemexpress Febantel Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Shanghai Haoyuan Chemexpress Febantel Products Offered
7.14.5 Shanghai Haoyuan Chemexpress Recent Development
7.15 Shanghai Aladdin Bio-Chem Technology
7.15.1 Shanghai Aladdin Bio-Chem Technology Company Information
7.15.2 Shanghai Aladdin Bio-Chem Technology Business Overview
7.15.3 Shanghai Aladdin Bio-Chem Technology Febantel Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Shanghai Aladdin Bio-Chem Technology Febantel Products Offered
7.15.5 Shanghai Aladdin Bio-Chem Technology Recent Development
8 Febantel Manufacturing Cost Analysis
8.1 Febantel Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Febantel
8.4 Febantel Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Febantel Distributors List
9.3 Febantel Customers
10 Febantel Market Dynamics
10.1 Febantel Industry Trends
10.2 Febantel Market Drivers
10.3 Febantel Market Challenges
10.4 Febantel Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Febantel was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 136
USD 3950.00
(Single User License)
The global Febantel market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 138
USD 2900.00
(Single User License)
The global Febantel market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 153
USD 4900.00
(Single User License)
The global market for Febantel was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 120
USD 3950.00
(Single User License)
The global market for Febantel was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 104
USD 2900.00
(Single User License)
The global Febantel market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-15
Pages: 110
USD 4900.00
(Single User License)
The global market for Febantel was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 136
USD 3950.00
(Single User License)
The global Febantel market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 113
USD 2900.00
(Single User License)
The global market for Febantel was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 136
The global Febantel market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 138
The global Febantel market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 153
The global market for Febantel was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 120
The global market for Febantel was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 104
The global Febantel market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-15
Pages: 110
The global market for Febantel was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 136
The global Febantel market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 113
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now